(Q37974152)

26 August 2017

0 references

Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies (English)

1 reference

26 August 2017

0 references

1 reference

3

A Wolk

1 reference

26 August 2017

A Discacciati

1

1 reference

26 August 2017

N Orsini

series ordinal

2

1 reference

26 August 2017

publication date

6 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

23

1 reference

26 August 2017

issue

7

1 reference

26 August 2017

page(s)

1665-1671

1 reference

26 August 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Circulating steroid hormones and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Body size and composition and prostate cancer risk: systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Risk factors for prostate cancer incidence and progression in the health professionals follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Obesity and prostate cancer: making sense out of apparently conflicting data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Body-Mass Index and Mortality among 1.46 Million White Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Effects of age on validity of self-reported height, weight, and body mass index: findings from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

High-grade prostate cancer is associated with low serum testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

Anthropometrics and Prostate Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR603

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDR603

1 reference

26 August 2017

1 reference